Paratek Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use…

Biotechnology
US, Boston [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PRTK's Analysis
CIK: 1178711 CUSIP: 699374302 ISIN: US6993743029 LEI: - UEI: -
Secondary Listings
PRTK has no secondary listings inside our databases.